Shares of Avalon Globocare Corp (OTCMKTS:AVCO) traded up 5% during trading on Monday . The stock traded as high as $1.74 and last traded at $1.67, 124,900 shares traded hands during trading. A decline of 62% from the average session volume of 325,950 shares. The stock had previously closed at $1.59.
The firm’s 50 day simple moving average is $1.97 and its 200 day simple moving average is $2.43.
Avalon Globocare (OTCMKTS:AVCO) last posted its quarterly earnings results on Thursday, August 15th. The company reported ($0.06) EPS for the quarter. The business had revenue of $0.40 million for the quarter. Avalon Globocare had a negative return on equity of 81.16% and a negative net margin of 365.09%.
Avalon Globocare Company Profile (OTCMKTS:AVCO)
Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology.
Featured Article: Stock Selection – What is cash flow?
Receive News & Ratings for Avalon Globocare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon Globocare and related companies with MarketBeat.com's FREE daily email newsletter.